Elevance Health, Inc. Common Stock (ELV)

Elevance Health, Inc. (NYSEELV) reported fourth quarter and full year 2024 results.

Elevance Health (NYSEELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Elevance Health Inc. (NASDAQELV) to determine whether certain Elevance officers and directors violated securities laws and breached fiduciary duties to shareholders. Elevance is a healthcare company that supports consumers, families, and communities across the entire care journey.

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of the core Blue Cross Blue Shield (BCBS)-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) [NYSE: ELV], as well as its life insurance subsidiaries. These companies collectively are referred to as Anthem Health. At the same time, AM Best has affirmed the Long-Term ICR of “bbb+” (Good), the Long- and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of Elevance and the Long-Term IR on the existing surplus notes of Anthem Insurance Companies, Inc. (Indianapolis, IN).

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at the UBS Global Healthcare Conference in Rancho Palos Verdes, California on November 12, at 7:15 a.m. Pacific Standard Time (PST) / 10:15 a.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here.

Elevance Health (NYSEELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich will lead Elevance Health's investor relations efforts, providing strategic leadership to support the company’s growth initiatives and strengthen relationships within the investment community. He will also serve as a member of the company’s executive leadership team and will report directly to Mark Kaye, Executive Vice President and Chief Financial Officer. Mr. Rich succeeds Stephen Tanal, who now serves as Chief Financial Officer for Elevance Health’s Government Health Benefits business.

Elevance Health, Inc. (NYSEELV) reported third quarter 2024 results.

Elevance Health (NYSEELV) will release third quarter 2024 financial results on October 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Everybody loves finding a bargain or getting a good deal, and it's no different when it comes to stocks. The RSI indicator is a great way to find them.

Elevance Health and its philanthropic arm, Elevance Health Foundation, are committed to strengthening the health of communities across the U.S. through community resiliency and disaster response efforts related to Hurricane Helene.

The Whole Health Index (WHI), created by Elevance Health, Inc. (NYSEELV) physicians, data scientists, and researchers, is a first-of-its-kind assessment of health. Using a scale of 0 to 100, the WHI can evaluate a person or group’s relative health over time and assess the physical, behavioral, and social factors that influence it.

Irvington Preparatory Academy today unveiled their first ever weight room and fitness space, provided by Elevance Health in partnership with the Impact Fitness Foundation (IFF), a national nonprofit that provides fitness resources to schools. The facility upgrade marks the third Indianapolis high school to receive a new fitness space in celebration of the Elevance Health Women’s Fort Myers Tip-Off, a pre-season collegiate basketball tournament that takes place in November.

Molina Healthcare's Q2 earnings and strategic acquisitions fuel a surge in its stock price, signaling the potential for continued growth.

Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.

Elevance Health, Inc. (NYSEELV) reported second quarter 2024 results.

Elevance Health released its annual Impact Report, highlighting its continued evolution from a traditional health insurance benefits company to a diversified healthcare services organization.

Elevance Health (NYSEELV) will release second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here.

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at Bernstein's 40th Annual Strategic Decisions Conference in New York City, on May 31 at 9:00 a.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here.

Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential

Elevance Health, Inc. (NYSEELV) reported first quarter 2024 results.

Elevance Health, Inc. (NYSEELV) and Clayton, Dubilier & Rice (CD&R) announced an agreement to form a strategic partnership to accelerate innovation in primary care delivery, enhance the healthcare experience, and improve health outcomes. This effort, which will operate across multiple regions of the United States, will bring together certain care delivery and enablement assets of Elevance Health’s Carelon Health and CD&R portfolio companies, apree health and Millennium Physician Group (MPG).

Elevance Health (NYSEELV) will release first quarter 2024 financial results on April 18, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:

Elevance Health (NYSEELV) today announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.

Elevance Health (NYSEELV) announced today that senior management is scheduled to present at the Cowen 44th Annual Health Care Conference in Boston on March 5, at 2:50 p.m. Eastern Standard Time (EST). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the webcast here.